Loader

Pathways

PathWhiz ID Pathway Meta Data

PW123981

Pw123981 View Pathway
metabolic

Selenocompound Metabolism

Arabidopsis thaliana
The metabolism of selenium and its derived compounds begins with selenite, which enters plant cells through sulfate channels. Before it can enter the chloroplast to be further metabolised, with the help of thioredoxin reductase 2 it reacts with hydrogen ions to become hydrogen selenide, oxidizing NADPH in the process. Hydrogen selenide is then transported into the chloroplast, where it reacts with L-alanine and an oxidized electron acceptor to produce selenocysteine. This is then combined with O-succinyl-L-homoserine to produce selenocystathionine. Aided by cystathionine beta-lyase, selenocystathionine is then hydrolyzed and yields pyruvic acid and selenohomocysteine. After one more reaction involving 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 2, selenomethionine is produced. This is a form in which selenium is commonly found in vascular plants and can be further metabolised for different uses. Diphosporic acid, S-methyl-methionine, and methylselenic acid are all produced from selenomethionine by different chemical reactions. Although selenium is not considered essential for many vascular plants, and may even be harmful at high concentrations, its presence has been shown to aid in a number of biological processes, such as photosynthesis and maintenance of general cell function.

PW122495

Pw122495 View Pathway
metabolic

Selenocompound Metabolism

Danio rerio

PW122340

Pw122340 View Pathway
metabolic

Selenocompound Metabolism

Drosophila melanogaster

PW124156

Pw124156 View Pathway
metabolic

Selenocompound metabolism

Arabidopsis thaliana

PW002472

Pw002472 View Pathway
metabolic

Selenocompound Metabolism

Saccharomyces cerevisiae
The the metabolism of selenocompounds starts with Selenocysteine being metabolized by a CGS resulting in the release of Seleno-cystathionine. The resulting compound is metabolized by a CBL resulting in the release of selenohomocysteine. The resulting compound reacts with MET resulting in the release of a seleno-methionine. Selenomethionine can be either metabolized into Seleno-methionyl-tRNA or a Methyl-selenol. Methyl-selenol can also be the result of Methyl-selenic acid reacting with a thioredoxin reductase or Se-methyl-selenocysteine reacting through a CTH.

PW122494

Pw122494 View Pathway
metabolic

Selenocompound Metabolism

Xenopus laevis

PW075771

Pw075771 View Pathway
metabolic

Selenocompound Metabolism

Homo sapiens
Selenate is the major inorganic selenocompound found in both animal and plant tissues. Selenocysteine is the predominant selenoamino acid in tissues when inorganic selenium is given to animals. Selenomethionine is the major selenocompound found initially in animals given this selenoamino acid, but is converted with time afterwards to selenocysteine. Selenomethionine is the major selenocompound in cereal grains, grassland legumes and soybeans. Selenomethionine can also be the major selenocompound in selenium enriched yeast, but the amount can vary markedly depending upon the growth conditions.

PW146261

Pw146261 View Pathway
drug action

Selenomethionine Drug Metabolism Action Pathway

Homo sapiens

PW146137

Pw146137 View Pathway
drug action

Selenomethionine Se-75 Drug Metabolism Action Pathway

Homo sapiens

PW128107

Pw128107 View Pathway
drug action

Selexipag Action Pathway

Homo sapiens
Selexipag is a non-prostanoid prostacyclin receptor agonist, also known as Uptravi typically used to treat pulmonary arterial hypertension. Selexipag is a selective prostacyclin receptor agonist, it is administered orally and is metabolized by carboylesterase1 into its active metabolite (ACT-333679). The metabolite has a high selectivity for prostacyclin receptor that activates it and subsequent G coupled protein, Gs, that increases cAMP levels. Increased cAMP levels leads to inhibited platelet aggregation and activation.